(Q54414113)

29 May 2018

title

Prevention of Colitis-Associated Carcinogenesis with Infliximab (English)

1 reference

https://api.crossref.org/works/10.1158/1940-6207.CAPR-09-0272

22 June 2024

1 reference

Yoon Jae Kim

1

1 reference

29 May 2018

Kyung Sook Hong

2

1 reference

29 May 2018

Jun Won Chung

3

1 reference

29 May 2018

Ju Hyun Kim

4

1 reference

29 May 2018

Ki Baik Hahm

5

1 reference

29 May 2018

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20736334

22 June 2024

publication date

24 August 2010

1 reference

29 May 2018

full work available at URL

https://cancerpreventionresearch.aacrjournals.org/content/canprevres/3/10/1314.full.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20736334

https://aacrjournals.org/cancerpreventionresearch/article-pdf/3/10/1314/2247781/1314.pdf

22 June 2024

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1158/1940-6207.CAPR-09-0272

Cancer Prevention Research

22 June 2024

published in

1 reference

29 May 2018

volume

3

1 reference

29 May 2018

issue

10

1 reference

29 May 2018

page(s)

1314-1333

1 reference

29 May 2018

Course of ulcerative colitis: analysis of changes in disease activity over years

cites work

1

1 reference

https://api.crossref.org/works/10.1158/1940-6207.CAPR-09-0272

Colitis and cancer: a tale of inflammatory cells and their cytokines

22 June 2024

5

1 reference

https://api.crossref.org/works/10.1158/1940-6207.CAPR-09-0272

Medical therapy for Crohn's disease: top-down or step-up?

22 June 2024

6

1 reference

https://api.crossref.org/works/10.1158/1940-6207.CAPR-09-0272

Controversies in the treatment of Crohn's disease: the case for an accelerated step-up treatment approach

22 June 2024

7

1 reference

https://api.crossref.org/works/10.1158/1940-6207.CAPR-09-0272

Crohn's disease: step up or top down therapy

22 June 2024

8

1 reference

https://api.crossref.org/works/10.1158/1940-6207.CAPR-09-0272

Cellular mechanisms of TNF function in models of inflammation and autoimmunity

22 June 2024

9

1 reference

https://api.crossref.org/works/10.1158/1940-6207.CAPR-09-0272

TNF: a master switch for inflammation to cancer

22 June 2024

10

1 reference

https://api.crossref.org/works/10.1158/1940-6207.CAPR-09-0272

TNFalpha blockade in human diseases: mechanisms and future directions

22 June 2024

11

1 reference

https://api.crossref.org/works/10.1158/1940-6207.CAPR-09-0272

Infliximab induces apoptosis in monocytes from patients with chronic active Crohn's disease by using a caspase-dependent pathway

22 June 2024

12

1 reference

https://api.crossref.org/works/10.1158/1940-6207.CAPR-09-0272

Loss of transgelin in repeated bouts of ulcerative colitis-induced colon carcinogenesis.

22 June 2024

13

1 reference

https://api.crossref.org/works/10.1158/1940-6207.CAPR-09-0272

Lessons from genetically engineered animal models. VII. Apoptosis in intestinal epithelium: lessons from transgenic and knockout mice

22 June 2024

15

1 reference

https://api.crossref.org/works/10.1158/1940-6207.CAPR-09-0272

Matrix metalloproteinase levels are elevated in inflammatory bowel disease

22 June 2024

16

1 reference

https://api.crossref.org/works/10.1158/1940-6207.CAPR-09-0272

Biological therapies in inflammatory bowel disease: top-down or bottom-up?

22 June 2024

17

1 reference

https://api.crossref.org/works/10.1158/1940-6207.CAPR-09-0272

Signaling pathway via TNF-alpha/NF-kappaB in intestinal epithelial cells may be directly involved in colitis-associated carcinogenesis

22 June 2024

18

1 reference

https://api.crossref.org/works/10.1158/1940-6207.CAPR-09-0272

Cancer and the chemokine network

22 June 2024

19

1 reference

https://api.crossref.org/works/10.1158/1940-6207.CAPR-09-0272

Inflammation and cancer: how hot is the link?

22 June 2024

20

1 reference

https://api.crossref.org/works/10.1158/1940-6207.CAPR-09-0272

Tumour necrosis factor and cancer

22 June 2024

21

1 reference

https://api.crossref.org/works/10.1158/1940-6207.CAPR-09-0272

Mast cells are an important cellular source of tumour necrosis factor alpha in human intestinal tissue

22 June 2024

22

1 reference

https://api.crossref.org/works/10.1158/1940-6207.CAPR-09-0272

IX. Mast cell-deficient mice and intestinal biology

22 June 2024

23

1 reference

https://api.crossref.org/works/10.1158/1940-6207.CAPR-09-0272

Tumour-educated macrophages promote tumour progression and metastasis

22 June 2024

24

1 reference

https://api.crossref.org/works/10.1158/1940-6207.CAPR-09-0272

Dysplasia and cancer in the dextran sulfate sodium mouse colitis model. Relevance to colitis-associated neoplasia in the human: a study of histopathology, B-catenin and p53 expression and the role of inflammation

22 June 2024

25

1 reference

https://api.crossref.org/works/10.1158/1940-6207.CAPR-09-0272

Colon carcinogenesis in inflammatory bowel disease: applying molecular genetics to clinical practice

22 June 2024

26

1 reference

https://api.crossref.org/works/10.1158/1940-6207.CAPR-09-0272

Mutations in the p53 gene: an early marker of neoplastic progression in ulcerative colitis.

22 June 2024

27

1 reference

https://api.crossref.org/works/10.1158/1940-6207.CAPR-09-0272

Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: a cancer-prone chronic inflammatory disease

22 June 2024

30

1 reference

https://api.crossref.org/works/10.1158/1940-6207.CAPR-09-0272

Development of colonic neoplasia in p53 deficient mice with experimental colitis induced by dextran sulphate sodium

22 June 2024

31

1 reference

https://api.crossref.org/works/10.1158/1940-6207.CAPR-09-0272

Inflammation and cancer: an ancient link with novel potentials.

22 June 2024

32

1 reference

https://api.crossref.org/works/10.1158/1940-6207.CAPR-09-0272

Helicobacter pylori and gastric cancer: a new paradigm for inflammation-associated epithelial cancers.

22 June 2024

33

1 reference

https://api.crossref.org/works/10.1158/1940-6207.CAPR-09-0272

Oxidative stress and ulcerative colitis-associated carcinogenesis: studies in humans and animal models

22 June 2024

34

1 reference

https://api.crossref.org/works/10.1158/1940-6207.CAPR-09-0272

Regulation of tissue homeostasis by NF-kappaB signalling: implications for inflammatory diseases

22 June 2024

35

1 reference

https://api.crossref.org/works/10.1158/1940-6207.CAPR-09-0272

Signal integration by JNK and p38 MAPK pathways in cancer development

22 June 2024

36

1 reference

https://api.crossref.org/works/10.1158/1940-6207.CAPR-09-0272

Chimeric anti-TNF-α monoclonal antibody cA2 binds recombinant transmembrane TNF-α and activates immune effector functions

22 June 2024

37

1 reference

https://api.crossref.org/works/10.1158/1940-6207.CAPR-09-0272

Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis

22 June 2024

38

1 reference

https://api.crossref.org/works/10.1158/1940-6207.CAPR-09-0272

Role of matrix metalloproteinases in intestinal inflammation

22 June 2024

39

1 reference

https://api.crossref.org/works/10.1158/1940-6207.CAPR-09-0272

Suppression of colitis-related mouse colon carcinogenesis by a COX-2 inhibitor and PPAR ligands

22 June 2024

40

1 reference

https://api.crossref.org/works/10.1158/1940-6207.CAPR-09-0272

Colonic crypt organization and tumorigenesis

22 June 2024

41

1 reference

https://api.crossref.org/works/10.1158/1940-6207.CAPR-09-0272

Tumor formation is correlated with expression of beta-catenin-accumulated crypts in azoxymethane-induced colon carcinogenesis in mice

22 June 2024

42

1 reference

https://api.crossref.org/works/10.1158/1940-6207.CAPR-09-0272

The risk of colorectal cancer in ulcerative colitis: a meta-analysis

22 June 2024

43

1 reference

https://api.crossref.org/works/10.1158/1940-6207.CAPR-09-0272

Cancer prevention in inflammatory bowel disease and the chemoprophylactic potential of 5-aminosalicylic acid

22 June 2024

44

1 reference

https://api.crossref.org/works/10.1158/1940-6207.CAPR-09-0272

5-aminosalicylic acid given in the remission stage of colitis suppresses colitis-associated cancer in a mouse colitis model

22 June 2024

45

1 reference

https://api.crossref.org/works/10.1158/1940-6207.CAPR-09-0272

22 June 2024

Identifiers

1 reference

29 May 2018

1 reference

29 May 2018